The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes

GLIA

Volumn 57, Issue 7, 2009, Pages 791-806

  Vignali, M ^a   Benfenati, V ^a   Caprini, M ^a   Anderova, M ^b   Nobile, M ^c   Ferroni, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c CNR   (Italy)

Author keywords

Brain homeostasis; Cortical astroglia; Endocannabinoids; NG2 glia; Potassium conductance

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CALCIUM ION; CANNABINOID RECEPTOR; ENDOCANNABINOID; ION CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CALCIUM SIGNALING; CELL FUNCTION; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM FUNCTION; CHANNEL GATING; CONTROLLED STUDY; DELAYED OUTWARD RECTIFIER POTASSIUM CURRENT; ELECTROPHYSIOLOGY; HOMEOSTASIS; MEMBRANE LEAFLET; MOLECULAR INTERACTION; NERVE CELL CULTURE; NERVE EXCITABILITY; NEUROMODULATION; NEWBORN; NONHUMAN; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; SIGNAL TRANSDUCTION; SYNCYTIUM;

ANIMALS; ANTIGENS; ARACHIDONIC ACIDS; ASTROCYTES; CALCIUM; CELL MEMBRANE; CELLS, CULTURED; CEREBRAL CORTEX; CYTOSOL; DELAYED RECTIFIER POTASSIUM CHANNELS; ENDOCANNABINOIDS; GLYCERIDES; MEMBRANE POTENTIALS; MICROGLIA; NEURONS; POLYUNSATURATED ALKAMIDES; POTASSIUM; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, CANNABINOID;

EID: 66249127223     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20807     Document Type: Article

References (110)

1. Anderova M, Antonova T, Petrík D, Neprasova H, Chvatal A, Sykova E. 2004. Voltage-dependent potassium currents in hypertrophied rat astrocytes after a cortical stab wound. Glia 48:311-326.
2. Barres BA, Koroshetz WJ, Chun LL, Corey DP. 1990. Ion channel expression by white matter glia: The type-1 astrocyte. Neuron 5:527-544.
3. Bekar LK, Loewen ME, Cao K, Sun X, Leis J, Wang R, Forsyth GW, Walz W. 2005. Complex expression and localization of inactivating Kv channels in cultured hippocampal astrocytes. J Neurophysiol 93:1699-1709.
4. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. 1997. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277:1094-1097.
5. Benfenati V, Amiry-Moghaddam M, Caprini M, Mylonakou M, Rapisarda C, Ottersen P, Ferroni S. 2007. Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes. Neuroscience 148:876-892.
6. Bojesen IN, Hansen HS. 2003. Binding of anandamide to bovine serum albumin. J Lipid Res 44:1790-1794.
7. Bordey A, Lyonos SA, Hablitz JJ, Sontheimer H. 2001. Electrophysiological characteristics of reactive astrocytes in experimental cortical dysplasia. J Neurophysiol 85:1719-1731.
8. Bordey A, Sontheimer H. 1997. Postnatal development of ionic currents in rat hippocampal astrocytes in situ. J Neurophysiol 78:461-477.
9. + currents by 4-AP. J Neurophysiol 82:3476-3487.
10. Bordey A, Sontheimer H. 2000. Ion channel expression by astrocytes in situ: Comparison of different CNS regions. Glia 30:27-38.
11. Bouaboula M, Bourrie B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P. 1995. Stimulation of cannabionoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270:13973-13980.
12. Breivogel CS, Griffin G, Di Marzo V, Martin BR. 2001. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155-163.
13. Brown DA, London E. 2000. Structure and function of sphingolipid-and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224.
14. Butt AM, Kalsi A. 2006. Inwardly rectifying potassium channels (Kir) in central nervous system glia: A special role for Kir4.1 in glial functions. J Cell Mol Med 10:33-44.
15. 2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol 2:69-82.
16. Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yanh W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. 2004. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65:999-1007.
17. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. 2001. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20:7033-7040.
18. Chevaleyre V, Takahashi KA, Castillo PE. 2006. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37-76.
19. Dainese E, Oddi S, Bari M, Maccarrone M. 2007. Modulation of the endocannabinoid system by lipid rafts. Curr Med Chem 14:2702-2715.
20. + homeostasis and altered electrophysiological properties of post-traumatic hippocampal glia. J Neurosci 19:8152-8162.
21. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agrò A, Di Marzo V. 2001. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856-12863.
22. 2 receptor-mediated actions of anandamide in mouse brain. J Neurochem 75:2434-2444.
23. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
24. Evans RM, Scott RH, Ross RA. 2004. Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol 141:1223-1233.
25. Facchinetti F, Del Giuduce E, Furegato S, Passarotto M, Leon A. 2003. Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide. Glia 41:161-168.
26. Fan P. 1995. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol 73:907-910.
27. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA. 1993. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90:7656-7660.
28. Ferroni S, Marchini C, Schubert P, Rapisarda C. 1995. Two distinct inwardly rectifying conductances are expressed in long-term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. FEBS Lett 367:319-325.
29. Ferroni S, Valente P, Caprini M, Nobile M, Schubert P, Rapisarda C. 2003. Arachidonic acid activates an open rectifier potassium channel in cultured rat cortical astrocytes. J Neurosci Res 72:363-372.
30. Fielding CJ, Fielding PE. 2003. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta 1610:219-228.
31. Fisyunov A, Tsintsadze V, Min R, Burnashev N, Lozovaya N. 2006. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. J Neurophysiol 96:1267-1277.
32. Franklin A, Parmentier-Batteur S, Walter L, Greenberg DA, Stella N. 2003. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23: 7767-7775.
33. + channels in rat hippocampal astrocytes. J Neurosci 23:1678-1687.
34. Gomez Del Pulgar T, De Ceballos ML, Guzman M, Velasco G. 2002. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 277:36527-36533.
35. Guo J, Ikeda SR. 2004. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65:665-674.
36. Hamill OP, Marty A, Neher E, Sackmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high resolution current recording from cells and cell free membrane patches. Pflugers Arch 391:85-100.
37. Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ, Bickler PE. 1998. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 70:671-676.
38. Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernandez-Ruiz JJ, Hansen HS. 2001. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem 78: 1415-1427.
39. Hansen HS, Moesgaard B, Hansen HH, Schousboe A, Petersen G. 1999. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. Lipids 34:327-330.
40. 9-tetrahydro-cannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol Pharmacol 69:991-997.
41. Hillard CJ, Jarrahian A. 2003. Cellular accumulation of anandamide: Consensus and controversy. Br J Pharmacol 140:802-808.
42. Irving AJ, Coutts AA, Harvey J, Rae MG, Mackie K, Bewick GS, Pertwee RG. 2000. Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience 98:253-262.
43. Jabs R, Pivneva T, Huttmann K, Wyczynski A, Nolte C, Kettenmann H, Steinhauser C. 2005. Synaptic transmission onto hippocampal glial cells with hGFAP promoter activity. J Cell Sci 118:3791-3803.
44. Jacobsson SOP, Wallin T, Fowler CJ. 2001. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther 299:951-959.
45. Jung M, Calassi R, Rinaldi-Carmona M, Cardenot P, Le Fur G, Soubrie P, Oury-Donat F. 1997. Characterization of CB1 receptors on rat neuronal cell cultures: Binding and functional studies using the selective receptor antagonist SR141716A. J Neurochem 68:402-409.
46. + currents in rat dorsal root ganglion neurons. Brain Res 1062:39-47.
47. + conductances in glial cells of mouse hippocampal brain slices. Glia 15:173-187.
48. Lauckner JE, Jensen JB, Chen HY, Lu HC, Mackie K. 2008. GPR55 is a cannabinoid receptor that increases calcium and inhibits M current. Proc Natl Acad Sci USA 105:2699-2704.
49. Lay L, Angus JS, Wright CE. 2000. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and in mouse. Eur J Pharmacol 391:151-161.
50. Lozovaya N, Yatsenko N, Beketov A, Tsintsadze T, Burnashev N. 2005. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. J Neurosci 25:7499-7506.
51. Lynch DL, Reggio PH. 2005. Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: Probing structure and dynamics. Med Chem 48:4824-4833.
52. MacFarlane SN, Sontheimer H. 1997. Electrophysiological changes that accompany reactive gliosis in vitro. J Neurosci 17:7316-7329.
53. MacFarlane SN, Sontheimer H. 2000a. Modulation of Kv1.5 currents by Src tyrosine phosphorylation: Potential role in the differentiation of astrocytes. J Neurosci 20:5245-5253.
54. MacFarlane SN, Sontheimer H. 2000b. Changes in ion channel expression accompany cell cycle progression of spinal cord astrocytes. Glia 30:39-48.
55. + channel TASK-1. EMBO J 20:47-54.
56. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Ortega Gutiérrez S, Van der Stelt M, López-Rodríguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C, Lutz B. 2003. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84-88.
57. Marsicano G, Moosman B, Herman H, Lutz B, Behl C. 2002. Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1. J Neurochem 80:448-456.
58. Martens JR, O'Connell K, Tamkun M. 2004. Targeting of ion channels to membrane microdomains: Localization of Kv channels to lipid rafts. Trends Pharmacol Sci 25:16-21.
59. Matthias K, Kirchhoff F, Seifert G, Huttmann K, Matyash M, Kettenmann H, Steinhauser C. 2003. Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus. J Neurosci 23: 1750-1758.
60. Mechoulam R, Shohami E. 2007. Endocannabinoids and traumatic brain injury. Mol Neurobiol 36:68-74.
61. Moldrich G, Wenger T. 2000. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21:1735-1742.
62. Molina-Holgado F, Molina-Holgado E, Guaza C, Rothwell NJ. 2002a. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J Neurosci Res 67:829-836.
63. Molina-Holgado E, Vela JM, Arevelo-Martin A, Almazan G, Molina-Holgado F, Borrel J, Guaza C. 2002b. Cannabinoids promote oligodentrocyte progenitor survival: Involvement of cannabinoid receptor and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci 22:9742-9753.
64. 2+ in endothelial cells. Br J Pharmacol 126:1593-1600.
65. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA. 1999. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19:2987-2995.
66. Navarrete M, Araque A. 2008. Endocannabinoids mediate neuron-astrocyte communication. Neuron 57:883-893.
67. + currents and volume regulation in astrocytes. Pflugers Arch 453:839-849.
68. Nishiyama A, Chang A, Trapp BD. 1999. NG2+ glial cells: A novel glial cell population in the adult brain. J Neuropathol Exp Neurol 58: 1113-1124.
69. Nowak L, Ascher P, Berwald-Netter Y. 1987. Ionic channels in mouse astrocytes in culture. J Neurosci 7:101-109.
70. + channels by membrane lipids. Science 304:265-270.
71. Oz M. 2006. Receptor-independent effects of endocannabinoids on ion channels. Curr Pharm Des 12:227-239.
72. Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, Morales M. 2003. The endogenous cannabinoid anandamide inhibits α7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther 306:1003-1010.
73. + currents in follicle-enclosed Xenopus oocytes. J Pharmacol Exp Ther 323:547-554.
74. Pannicke T, Faude F, Reichenbach A, Reichelt W. 2000. A function of delayed rectifier potassium channels in glial cells: Maintenance of an auxiliary membrane potential under pathological conditions. Brain Res 862:187-193.
75. Pearlman RJ, Aubrey KR, Vandenberg RJ. 2003. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. J Neurochem 84:592-601.
76. Pertwee RG, Ross RA. 2002. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66:101-121.
77. + channels. Neuropharmacology 35:983-991.
78. Pusch M, Neher H. 1988. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch 411:204-211.
79. Quandt FN, MacVicar BA. 1986. Calcium-activated potassium channels in cultured astrocytes. Neuroscience 19:29-41.
80. Rodriguez JJ, Mackie K, Pickel VM. 2001. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21:823-833.
81. Romero J, Hillard CJ, Calero M, Rábano A. 2002. Fatty acid amide hydrolase localization in the human central nervous system: An immunohistochemical study. Mol Brain Res 100:85-93.
82. Roy ML, Saal D, Perney T, Sontheimer H, Waxman SG, Kaczmarec LK. 1996. Manipulation of the delayed rectifier Kv1.5 potassium channel in glial cells by antisense oligodeoxynucleotides. Glia 18:177-184.
83. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. 2007. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152: 1092-1101.
84. Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C. 1999. Anandamide and WIN55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Eur J Neurosci 11:691-699.
85. Salio C, Doly S, Fischer J, Franzoni MF, Conrath M. 2002. Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neurosci Lett 329:13-16.
86. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF. 1999. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193-198.
87. Schlicker E, Kathmann M. 2001. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572.
88. Seifert G, Schilling K, Steinhauser C. 2006. Astrocyte dysfunction in neurological disorders: A molecular perspective. Nat Rev Neurosci 7:194-206.
89. Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK. 2005. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes. Glia 49:211-219.
90. Shivachar AC. 2007. Cannabinoids inhibit sodium-dependent, high affinity excitatory amino acid transport in cultured rat cortical astrocytes. Biochem Pharmacol 73:2004-2011.
91. 9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)- 4methyl-1H-Pyrazole-3-carboximide hydrochloride]. Biochem Pharmacol 51:669-676.
92. Simard M, Nedergaard M. 2004. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129:877-896.
93. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB. 2000. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
94. Smart SL, Bosma SL, Tempel BL. 1997. Identification of the delayed rectifier potassium channel, Kv16, in cultured astrocytes. Glia 20:127-134.
95. Stella N. 2004. Cannabinoid signaling in glial cells. Glia 48:267-277.
96. Tian X, Guo J, Yao F, Yang DP, Makriyannis A. 2005. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. J Biol Chem 280:29788-29795.
97. Van den Bossche I, Vanheel B. 2000. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. Br J Pharmacol 131:85-93.
98. 2+ influx via TRPV1 channels. EMBO J 24:3026-3037.
99. Van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisog no T, Bar PR, Veldink GA, Vliegenthart JF, Di Marzo V, Nicolay K. 2001. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci 21:8765-8771.
100. Venance L, Piomelli D, Glowinski J, Giaume C. 1995. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590-594.
101. Venance L, Sagan S, Giaume C. 1997. (R)-methanandamide inhibits receptor-induced calcium responses by depleting internal calcium stores in cultured astrocytes. Pflugers Arch 434:147-149.
102. Verkhratsky A, Steinhauser C. 2000. Ion channels in glial cells. Brain Res Brain Res Rev 32:380-412.
103. Vogel Z, Barg J, Levi R, Saya D, Heldman E, Mechoulam R. 1993. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61:352-355.
104. Volterra A, Meldolesi J. 2005. Astrocytes, from brain glue to communication elements: The revolution continues. Nat Rev Neurosci 6:626-640.
105. Wallraff A, Odermatt B, Willecke K, Steinhauser C. 2004. Distinct types of astroglial cells in the hippocampus differ in gap junction coupling. Glia 48:36-43.
106. Walter L, Dinh T, Stella N. 2004. ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J Neurosci 24:8068-8074.
107. Walter L, Franklin A, Witting A, Moller T, Stella N. 2002. Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem 277:20869-20876.
108. Walter L, Stella N. 2003. Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes. Glia 44:85-90.
109. Walz W. 2000. Controversy surrounding the existence of discrete functional classes of astrocytes in adult gray matter. Glia 31:95-103.
110. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. 2003. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424:434-438.